Simpson Thacher represented Goldman Sachs & Co. LLC, Itau BBA USA Securities, Inc., XP Investments US, LLC, Santander US Capital Markets LLC, BTG Pactual US Capital, LLC and J.P. Morgan Securities LLC as placement agents in connection with the follow on equity offering by Oncoclínicas do Brasil Serviços Médicos S.A. (“Oncoclínicas”) of 87,500,000 common shares. The offering was comprised of a primary offering of 20,000,000 common shares issued by Oncoclínicas and a secondary offering of 67,500,000 common shares sold by Josephina Fundo de Investimento em Participações Multiestratégia and Josephina II Fundo de Investimento em Participações Multiestratégia (investment funds managed by Goldman Sachs), and certain other selling shareholders. The common shares were offered to certain institutional investors in Brazil, to qualified institutional buyers in the United States under Rule 144A and to non-U.S. persons in reliance on Regulation S.
Oncoclínicas is one of the largest oncology, hematology and radiotherapy centers in Latin America. The shares of Oncoclínicas are traded on the Novo Mercado listing segment of the São Paulo Stock Exchange (B3 S.A. – Brasil, Bolsa, Balcão) under the symbol “ONCO3.”
The Simpson Thacher team for the transaction included Grenfel S. Calheiros, Luiz F. Noronha, Raissa Fini and Ariela Sznirer (Capital Markets); and Michael E. Mann (Tax – New York).